Other Species / Isoforms
  VEGFR3 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T128-p
EGTTAAStYVFVRDF
0 1
VEGFR3 (human) EGTTAASSYVFVRDF S128
VEGFR3 (mouse) EGTTAAStYVFVRDF T128-p
VEGFR3 (rat) EGTTAASTYVFVRDF T128
N166-ng
LVSIPGLnITLRSQS
0 1
VEGFR3 (human) LVSIPGLNVTLRSQS N166
VEGFR3 (mouse) LVSIPGLnITLRSQS N166-ng
VEGFR3 (rat) LVSIPGLNITLRSQS N166
N299-ng
SSILTIHnVSQNDLG
0 1
VEGFR3 (human) SSILTIHNVSQHDLG N299
VEGFR3 (mouse) SSILTIHnVSQNDLG N299-ng
VEGFR3 (rat) SSILTIHNVSQHDLG N299
N411-ng
SAAGLRQnISLELVV
0 1
VEGFR3 (human) SAAGLRRNISLELVV N411
VEGFR3 (mouse) SAAGLRQnISLELVV N411-ng
VEGFR3 (rat) SAAGLRQNISLELVV N411
N515-ng
TEFVEGKnKTVSKLV
0 1
VEGFR3 (human) TEFVEGKNKtVSKLV N515
VEGFR3 (mouse) TEFVEGKnKTVSKLV N515-ng
VEGFR3 (rat) TESVEGKNKTVSKLV N515
T517
FVEGKnKTVSKLVIQ
0 1
VEGFR3 (human) FVEGKNKtVSKLVIQ T517-p
VEGFR3 (mouse) FVEGKnKTVSKLVIQ T517
VEGFR3 (rat) SVEGKNKTVSKLVIQ T517
N527-ng
KLVIQDAnVSAMYKC
0 1
VEGFR3 (human) KLVIQNANVSAMYKC N527
VEGFR3 (mouse) KLVIQDAnVSAMYKC N527-ng
VEGFR3 (rat) KLVIQDANVSAMYKC N527
N582-ng
RLSCRADnYTYEHLR
0 1
VEGFR3 (human) LLSCQADSYKYEHLR S582
VEGFR3 (mouse) RLSCRADnYTYEHLR N582-ng
VEGFR3 (rat) RLSCRADNYTYEHLR N582
N594-ng
HLRWYRLnLSTLHDA
0 1
VEGFR3 (human) HLRWYRLNLSTLHDA N594
VEGFR3 (mouse) HLRWYRLnLSTLHDA N594-ng
VEGFR3 (rat) HLRWYRLNLSTLHDA N594
N683-ng
EAPRLTQnLTDLLVn
0 1
VEGFR3 (human) EAPRLTQNLTDLLVN N683
VEGFR3 (mouse) EAPRLTQnLTDLLVn N683-ng
VEGFR3 (rat) EAPRLTQNLTDLLVN N683
N690-ng
nLTDLLVnVSDSLEM
0 1
VEGFR3 (human) NLTDLLVNVSDSLEM N690
VEGFR3 (mouse) nLTDLLVnVSDSLEM N690-ng
VEGFR3 (rat) NLTDLLVNVRTSLEM N690
Y830
PLEEQCEYLSYDASQ
0 1
VEGFR3 (human) PLEEQCEyLSyDASQ Y830-p
VEGFR3 (mouse) PLEEQCEYLSYDASQ Y830
VEGFR3 (rat) PLEEQCEYLSYDVSQ Y830
Y833
EQCEYLSYDASQWEF
0 1
VEGFR3 (human) EQCEyLSyDASQWEF Y833-p
VEGFR3 (mouse) EQCEYLSYDASQWEF Y833
VEGFR3 (rat) EQCEYLSYDVSQWEF Y833
H853
HLGRVLGHGAFGKVV
0 1
VEGFR3 (human) HLGRVLGyGAFGKVV Y853-p
VEGFR3 (mouse) HLGRVLGHGAFGKVV H853
VEGFR3 (rat) HLGRVLGHGAFGKVV H853
S863
FGKVVEASAFGINKG
0 2
VEGFR3 (human) FGKVVEAsAFGIHKG S863-p
VEGFR3 (mouse) FGKVVEASAFGINKG S863
VEGFR3 (rat) FGKVVEASAFGINKG S863
S871
AFGINKGSSCDTVAV
0 1
VEGFR3 (human) AFGIHKGsSCDTVAV S871-p
VEGFR3 (mouse) AFGINKGSSCDTVAV S871
VEGFR3 (rat) AFGINKGSSCDTVAV S871
T886
KMLKEGATASEHRAL
0 1
VEGFR3 (human) KMLKEGAtASEHRAL T886-p
VEGFR3 (mouse) KMLKEGATASEHRAL T886
VEGFR3 (rat) KMLKEGATASEHRAL T886
S953-p
FNPYAEKsPEQRRRF
0 3
VEGFR3 (human) FSPCAEKSPEQRGRF S953
VEGFR3 (mouse) FNPYAEKsPEQRRRF S953-p
VEGFR3 (rat) FDPYAEKSPEQRRRF S953
S976
ADRRRPGSSDRALFT
0 1
VEGFR3 (human) LDRRRPGsSDRVLFA S976-p
VEGFR3 (mouse) ADRRRPGSSDRALFT S976
VEGFR3 (rat) ADRRRLGSTDRALFT S976
L986
RALFTRFLMGKGSAR
0 1
VEGFR3 (human) RVLFARFsKTEGGAR S986-p
VEGFR3 (mouse) RALFTRFLMGKGSAR L986
VEGFR3 (rat) RALFTRFLMGKGSAR L986
Y1063-p
FGLARDIykDPDyVR
2 108
VEGFR3 (human) FGLARDIykDPDyVR Y1063-p
VEGFR3 (mouse) FGLARDIykDPDyVR Y1063-p
VEGFR3 (rat) FGLARDIyKDPDyVR Y1063-p
K1064-ub
GLARDIykDPDyVRK
0 4
VEGFR3 (human) GLARDIykDPDyVRK K1064-ub
VEGFR3 (mouse) GLARDIykDPDyVRK K1064-ub
VEGFR3 (rat) GLARDIyKDPDyVRK K1064
Y1068-p
DIykDPDyVRKGSAR
1 112
VEGFR3 (mouse)
Y1068-p
VEGFR3 (rat)
Y1068-p
VEGFR3 (human) DIykDPDyVRKGSAR Y1068-p
VEGFR3 (mouse) DIykDPDyVRKGSAR Y1068-p
VEGFR3 (rat) DIyKDPDyVRKGSAR Y1068-p
S1163
PKARPAFSDLVEILG
0 1
VEGFR3 (human) PKARPAFsELVEILG S1163-p
VEGFR3 (mouse) PKARPAFSDLVEILG S1163
VEGFR3 (rat) PKARPAFSDLVEILG S1163
Y1230-p
CHSLAARyyNCVSFP
Upstream
2 1
Putative in vivo kinases:
  • VEGFR2 (mouse)
Treatment
  • VEGF
VEGFR3 (human) RHSLAARyyNWVsFP Y1230-p
VEGFR3 (mouse) CHSLAARyyNCVSFP Y1230-p
VEGFR3 (rat) CHSLAARYYNCVSFP Y1230
Y1231-p
HSLAARyyNCVSFPG
Upstream
2 1
Putative in vivo kinases:
  • VEGFR2 (mouse)
Treatment
  • VEGF
VEGFR3 (human) HSLAARyyNWVsFPG Y1231-p
VEGFR3 (mouse) HSLAARyyNCVSFPG Y1231-p
VEGFR3 (rat) HSLAARYYNCVSFPG Y1231
S1235
ARyyNCVSFPGRLAR
0 11
VEGFR3 (human) ARyyNWVsFPGCLAR S1235-p
VEGFR3 (mouse) ARyyNCVSFPGRLAR S1235
VEGFR3 (rat) ARYYNCVSFPGRLVR S1235
K1253
TPGSSRMKTFEELPM
0 2
VEGFR3 (human) TRGSSRMkTFEEFPM K1253-ub
VEGFR3 (mouse) TPGSSRMKTFEELPM K1253
VEGFR3 (rat) APGSSRMKTFEELPM K1253
Y1265-p
LPMTPTTyKASMDNQ
Upstream
1 0
Putative in vivo kinases:
  • VEGFR2 (mouse)
Treatment
  • VEGF
VEGFR3 (human) FPMTPTTYKGSVDNQ Y1265
VEGFR3 (mouse) LPMTPTTyKASMDNQ Y1265-p
VEGFR3 (rat) LPMTPTTYKASVDNQ Y1265
K1300
PEGSFSCKGPGQHMD
0 1
VEGFR3 (human) QESGFSCkGPGQNVA K1300-ub
VEGFR3 (mouse) PEGSFSCKGPGQHMD K1300
VEGFR3 (rat) QEGSFSRKDPGQHMD K1300
Y1333-p
AQGGKVFyNNEyGEV
Upstream
2 1
Treatment
  • M-CSF
VEGFR3 (human) ARGGQVFyNSEyGEL Y1333-p
VEGFR3 (mouse) AQGGKVFyNNEyGEV Y1333-p
VEGFR3 (rat) AQGGKVFYNNEYGEV Y1333
Y1337-p
KVFyNNEyGEVSQPC
Upstream
Downstream
4 3
Effects on Biological Processes:
  • cell growth, altered
Treatment
  • M-CSF
  • VEGF
VEGFR3 (human) QVFyNSEyGELSEPS Y1337-p
VEGFR3 (mouse) KVFyNNEyGEVSQPC Y1337-p
VEGFR3 (rat) KVFYNNEYGEVSQPC Y1337
Y1363-p
TFFADSSy_______
Upstream
2 0
Treatment
  • M-CSF
  • VEGF
VEGFR3 (human) TFFTDNSY_______ Y1363
VEGFR3 (mouse) TFFADSSy_______ Y1363-p
VEGFR3 (rat) TFFADSNY_______ Y1363